Considering a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits distinct behaviors. It functions primarily as a cyclooxygenase agent, largely inhibiting cyclooxygenase-2 (COX-2), an catalyst participating in prostaglandin synthesis . This specific inhibition generates diminished inflammation and pain , delivering therapeutic effects f… Read More